Sujay Kango News Today : Breaking News, Live Updates & Top Stories | Vimarsana

File New Definitive Consent Materials to Remove Entire MEI Pharma Board for Cause and Add Advisory Proposal Requesting the Return of Capital to...

Infinity Pharmaceuticals, Inc. , a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced...

MEI Pharma Appoints Biotechnology Executive Sujay Kango to its Board of Directors SAN DIEGO, November 23, 2021 - MEI Pharma, Inc. , a late-stage pharmaceutical... | November 23, 2021

MEI Pharma Appoints Biotechnology Executive Sujay Kango to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace

Operator Good afternoon, ladies and gentlemen, and welcome to the Acceleron First Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to Ms. Jamie Bernard, Associate Director of Investor Relations at Acceleron. Please go ahead. Jamie A. Bernard -- Associate Director of Investor Relations Thanks, and welcome, everyone, to our first quarter 2021 earnings call. The press release reporting our financial results in addition to the presentation for today's webcast are available on the Investors & Media page of our corporate website at www.acceleron...